Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.41 |
| ▸ | USP14 | P54578 | 2/20 | 0.40 |
| ▸ | RORC | P51449 | 7/20 | 0.39 |
| ▸ | PGR | P06401 | 2/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29511674 | 0.97 | KDM4E (0.47) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL17772248 | 0.97 | KDM4E (0.47) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15250632 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15250620 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL18623540 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL18623536 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15250633 | 0.94 | ATM (0.50) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15248307 | 0.94 | ATM (0.53) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15250658 | 0.94 | ATM (0.53) | KDM4EATML3MBTL1PTGER4USP14 | |
| SCHEMBL15250660 | 0.94 | ATM (0.53) | KDM4EATML3MBTL1PTGER4USP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816021-B2 | Carbazole-based compound and organic light-emitting device including organic layer including the carbazole-based compound | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-10-19 | — | — | US | disclosed |
| US-20080174237-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE CARBAZOLE-BASED COMPOUND | SAMSUNG SDI CO., LTD. (KR) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080174237-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE CARBAZOLE-BASED COMPOUND | IK, POU5F1, OXA1L | KDM4E 2502/4885ATM 3836/4885L3MBTL1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.